The University of Chicago Header Logo

Connection

Nishant Agrawal to Cetuximab

Back to Details
This is a "connection" page, showing publications Nishant Agrawal has written about Cetuximab.
Nishant Agrawal
Connection Strength
0.034
Cetuximab
  1. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. J Clin Oncol. 2017 Feb 10; 35(5):490-497.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.